These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 38292868)

  • 1. Single-cell disulfidptosis regulator patterns guide intercellular communication of tumor microenvironment that contribute to kidney renal clear cell carcinoma progression and immunotherapy.
    Xu K; Li D; Qian J; Zhang Y; Zhang M; Zhou H; Hou X; Jiang J; Zhang Z; Sun H; Shi G; Dai H; Liu H
    Front Immunol; 2024; 15():1288240. PubMed ID: 38292868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling the hidden role of disulfidptosis in kidney renal clear cell carcinoma: a prognostic signature for personalized treatment.
    Ye Y; Zeng S; Hu X
    Apoptosis; 2024 Jun; 29(5-6):693-708. PubMed ID: 38296888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a prognostic model based on different disulfidptosis related genes typing for kidney renal clear cell carcinoma.
    Feng Y; Wang W; Jiang S; Liu Y; Wang Y; Zhan X; Zhu H; Du G
    Front Pharmacol; 2024; 15():1343819. PubMed ID: 38549669
    [No Abstract]   [Full Text] [Related]  

  • 4. Single-cell N
    Gao Y; Wang H; Chen S; An R; Chu Y; Li G; Wang Y; Xie X; Zhang J
    J Transl Med; 2022 May; 20(1):197. PubMed ID: 35509079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of single-cell ferroptosis regulation in intercellular communication and skin cutaneous melanoma progression and immunotherapy.
    Song B; Peng Y; Zheng Y; Zhu Y; Liu W; Wang K; Cui Z; Song B
    Cancer Immunol Immunother; 2023 Nov; 72(11):3523-3541. PubMed ID: 37638981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-cell communications shape tumor microenvironment and predict clinical outcomes in clear cell renal carcinoma.
    Chen LX; Zeng SJ; Liu XD; Tang HB; Wang JW; Jiang Q
    J Transl Med; 2023 Feb; 21(1):113. PubMed ID: 36765369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.
    Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X
    BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance.
    Mao JX; Li JJ; Lu XY; Zhong HX; Zhao YY; Zhu LY; Fu H; Ding GS; Teng F; Chen M; Guo WY
    Int Immunopharmacol; 2024 Jul; 136():112340. PubMed ID: 38820962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen metabolism-mediated intercellular communication in the tumor microenvironment influences liver cancer prognosis.
    Zhang Y; Qin N; Wang X; Liang R; Liu Q; Geng R; Jiang T; Liu Y; Li J
    Oncol Res; 2024; 32(3):563-576. PubMed ID: 38361757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration.
    Zhang C; Huang G; Yang J; Jiang Y; Huang R; Ye Z; Huang Y; Hu H; Xi X
    Front Immunol; 2023; 14():1197011. PubMed ID: 37383233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disulfidptosis status influences prognosis and therapeutic response in clear cell renal cell carcinoma.
    Deng W; Xie Z; Chen L; Li W; Li M
    Aging (Albany NY); 2024 Jan; 16(2):1249-1275. PubMed ID: 38271056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the prognostic role of lncRNAs associated with disulfidptosis-related genes in clear cell renal cell carcinoma.
    Sun Z; Wang J; Fan Z; Yang Y; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Liu Y; Yang Q; Ma B
    J Gene Med; 2024 Jan; 26(1):e3608. PubMed ID: 37897262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative prognostic modeling in ESCC: leveraging scRNA-seq and bulk-RNA for dendritic cell heterogeneity analysis.
    Shi M; Zhang H; Ma L; Wang X; Sun D; Feng Z
    Front Immunol; 2024; 15():1352454. PubMed ID: 38515748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell histone chaperones patterns guide intercellular communication of tumor microenvironment that contribute to breast cancer metastases.
    Xie J; Deng W; Deng X; Liang JY; Tang Y; Huang J; Tang H; Zou Y; Zhou H; Xie X
    Cancer Cell Int; 2023 Dec; 23(1):311. PubMed ID: 38057779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell dissection reveals the role of aggrephagy patterns in tumor microenvironment components aiding predicting prognosis and immunotherapy on lung adenocarcinoma.
    Sun X; Meng F; Nong M; Fang H; Lu C; Wang Y; Zhang P
    Aging (Albany NY); 2023 Dec; 15(23):14333-14371. PubMed ID: 38095634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma.
    Cai Z; He Y; Yu Z; Hu J; Xiao Z; Zu X; Li Z; Li H
    Front Immunol; 2022; 13():933241. PubMed ID: 36211378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which
    Xu K; Zhang Y; Yan Z; Wang Y; Li Y; Qiu Q; Du Y; Chen Z; Liu X
    Front Immunol; 2023; 14():1205250. PubMed ID: 37426643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning-driven prognostic analysis of cuproptosis and disulfidptosis-related lncRNAs in clear cell renal cell carcinoma: a step towards precision oncology.
    Chen R; Wu J; Che Y; Jiao Y; Sun H; Zhao Y; Chen P; Meng L; Zhao T
    Eur J Med Res; 2024 Mar; 29(1):176. PubMed ID: 38491523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma.
    Zheng A; Bai J; Ha Y; Yu Y; Fan Y; Liang M; Lu Y; Shen Z; Luo B; Jie W
    BMC Cancer; 2023 Feb; 23(1):135. PubMed ID: 36759775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.